Diseases & Disorders
(G30)
IRS Verified
DX Registered
990 on File
AMERICAN ASSOCIATION FOR CANCER RESEARCH FOUNDATION
Financial strength (30%)
68/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$52.9M
Total Revenue
$54.3M
Total Expenses
$4.8M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
88.5%
Fundraising Efficiency
18503.5%
Operating Reserve
1.06x
Liability-to-Asset
0.3%
Revenue Diversification
97.2%
Executive Compensation
$702K
Compared with Peers
FY 2024
Compared with 166 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
88.5% | 86.7% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
1.8% | 10.3% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
9.7% | 0.5% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
18503.5% | 280.6% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
1.1 mo | 7.8 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.3% | 28.9% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
97.2% | 90.7% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
178.6% | 7.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
160.3% | 7.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-2.6% | 1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $52.9M | $54.3M | $4.8M | 88.5% | 0 |
| 2023 | $19.0M | $20.9M | $6.2M | 74.4% | 0 |
| 2022 | $30.0M | $30.2M | $7.7M | 85.7% | 0 |
| 2021 | $44.0M | $43.9M | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.